The Ryanodine Receptor Calcium Channel of β-Cells

Molecular Regulation and Physiological Significance

  1. Md. Shahidul Islam
  1. From the Department of Molecular Medicine, Karolinska Institutet, Department of Endocrinology, Karolinska Hospital, Stockholm, Sweden

    Abstract

    The list of Ca2+ channels involved in stimulus-secretion coupling in β-cells is increasing. In this respect the roles of the voltage-gated Ca2+ channels and IP3 receptors are well accepted. There is a lack of consensus about the significance of a third group of Ca2+ channels called ryanodine (RY) receptors. These are large conduits located on Ca2+ storage organelle. Ca2+ gates these channels in a concentration- and time-dependent manner. Activation of these channels by Ca2+ leads to fast release of Ca2+ from the stores, a process called Ca2+-induced Ca2+ release (CICR). A substantial body of evidence confirms that β-cells have RY receptors. CICR by RY receptors amplifies Ca2+ signals. Some properties of RY receptors ensure that this amplification process is engaged in a context-dependent manner. Several endogenous molecules and processes that modulate RY receptors determine the appropriate context. Among these are several glycolytic intermediates, long-chain acyl CoA, ATP, cAMP, cADPR, NO, and high luminal Ca2+ concentration, and all of these have been shown to sensitize RY receptors to the trigger action of Ca2+. RY receptors, thus, detect co-incident signals and integrate them. These Ca2+ channels are targets for the action of cAMP-linked incretin hormones that stimulate glucose-dependent insulin secretion. In β-cells some RY receptors are located on the secretory vesicles. Thus, despite their low abundance, RY receptors are emerging as distinct players in β-cell function by virtue of their large conductance, strategic locations, and their ability to amplify Ca2+ signals in a context-dependent manner.

    Footnotes

    • Address correspondence and reprint requests to Md. Shahidul Islam, Associate Professor, Department of Molecular Medicine, Karolinska Institutet, Department of Endocrinology, Karolinska Hospital L1:02, S-171 76 Stockholm, Sweden. E-mail: shahidul.islam{at}molmed.ki.se.

      Received for publication 6 November 2001 and accepted in revised form 14 January 2002.

      [Ca2+]c, cytosolic free Ca2+ concentration; [Ca2+]m, mitochondrial Ca2+ concentration; CICR, Ca2+-induced Ca2+ release; ER, endoplasmic reticulum; FDP, fructose 1,6-diphosphate; KATP, ATP-sensitive potassium channel; IBMX, 3-isobutyl-1-methylxanthine; IP3R, IP3 receptor; NO, nitric oxide; PDE, phosphodiesterase; PKA, protein kinase A; RY, ryanodine.

    « Previous | Next Article »Table of Contents